Aecom (NYSE: ACM)

Aecom, together with its subsidiaries, engages in designing, building, financing, and operating infrastructure assets worldwide. The company operates through four segments: Design and Consulting Services, Construction Services, Management Services, and Aecom Capital.

Take a look at the 1-year chart of Aecom (NYSE: ACM) below with my added notations:

ACM had formed a key support at $32 (green) over the past few months. The stock was also declining against a down trending resistance line (red). These two levels combined had ACM stuck within a common chart pattern known as a descending triangle. Eventually, the stock would have to break one of those two levels, and last week ACM broke the support.

Continue Reading »

Acorda Therapeutics Inc (NASDAQ: ACOR)

Acorda Therapeutics, Inc., a biopharmaceutical company, identifies, develops, and commercializes therapies for neurological disorders in the United States.

Take a look at the 1-year chart of Acorda (NASDAQ: ACOR) below with added notations:

1-year chart of Acorda (NASDAQ: ACOR)

After dropping through the floor, ACOR has now fallen into a sideways trading range. While in the range, the stock has formed a key resistance level at $20 (red), and a $16 support (green). At some point the stock will have to break one of the two levels.

Continue Reading »

Dycom Industries, Inc. (NYSE: DY)

Dycom Industries, Inc. provides specialty contracting services in the United States and Canada. The company offers various specialty contracting services, including program management, engineering, construction, maintenance, and installation services, such as placement and splicing of fiber, copper, and coaxial cables to telecommunications providers.

Take a look at the 1-year chart of Dycom (NYSE: DY) below with my added notations:

1-year chart of Dycom (NYSE: DY)

DY has been on a steady decline over the past eight months, and during the most recent stretch the stock has created key price levels at the increments of $5 (blue). For example, the current level of resistance is $80, which was also prior support last month. $85 is the next level of resistance, and $90 after that.

Continue Reading »

Uxin Limited (NASDAQ: UXIN)

Uxin Limited, through its subsidiaries, operates an used car e-commerce platform in China. It operates Uxin Used Car, an application that provides consumers with customized car recommendation, financing, title transfer, delivery, insurance referral, warranty and other related services; and Uxin Auction, an application that helps business buyers to source vehicles through online auctions.

Take a look at the 1-year chart of Uxin (NASDAQ: UXIN) below with added notations:

After shooting higher back in June, UXIN has now fallen into a wide, sideways trading range. While in the range, the stock has formed a key resistance level at $7 (red), and a $5 support (green). At some point the stock will have to break one of the two levels.

Continue Reading »

Medpace (NASDAQ: MEDP)

Medpace Holdings, Inc., a clinical contract research organization, provides scientifically-driven outsourced clinical development services to the biotechnology, pharmaceutical, and medical device industries worldwide.

Take a look at the 1-year chart of Medpace (NASDAQ: MEDP) with the added notations:

During the past three months, MEDP had formed a very important level of support at $55 (red). Last week saw the stock break below that support. Not only does that imply lower prices for MEDP, but the $55 level will most likely act as resistance on future rallies.

Continue Reading »